Insulin “Made in Algeria” conquers the Arab market: revenues of €250 million expected by 2025

A new era is dawning for the Algerian pharmaceutical industry. The Biocare Group has just announced the imminent launch next week of its first entirely locally-produced insulin pen, Bio Mix and Bio Rapid. Read more…

Partager cette article:

NEWSLETTER

Inscrivez-vous gratuitement à la Newsletter pour être informé de nos actualités, nouveautés ?

Insulin “Made in Algeria” conquers the Arab market: revenues of €250 million expected by 2025

Share this article:

NEWSLETTER

Inscrivez-vous gratuitement à la Newsletter pour être informé de nos actualités, nouveautés ?

Articles associés

The Saidal method

To meet its development needs and expand its production and diversification capacities, the Saidal Group has taken over the WPS production site at Oued Smar, set up in 1998 in partnership with Sanofi Laboratories. Read more…

Lire la suite
Scroll to Top